Biography:
After obtaining her PhD degree from the University of Toulouse (France), G Inchauspé performed a post- doctoral training at the National Institute of Health (Bethesda USA). She moved in 1989 to the Lindsley Kimball Research Institute of the New York Blood Center as a Member Investigator and in 1995 joined the French National Institute of Health (INSERM) where she continued to pursue research on immunological and vaccine development against hepatitis C virus infection. Since 2005, the department she heads at the biotech Transgene (Lyon, France) has developed therapeutic vaccines against several chronic infectious diseases and more recently a novel immunotherapy to treat sepsis immunosuppression.
Title : MVA-based virotherapies in the treatment of infectious diseases